SAS does not generate funds that can be used for anything. A company actually loses money on SAS, it is a net cash drain. But a worthwhile one if it helps ex-trial participants and sustains interest in our pipeline. Hence it is a kind of investment.
The contributing funds from this investment will be well used and directly replaces funds that would otherwise have to come from shareholders.
I should add state while the PR called this a "financial investment", we are assuming it to be a grant and not a stock purchase. The latter is not common.
News 
Market Data 
Discover 
